Galectin-9-driven immune evasion constrains radiotherapy-induced systemic antitumor immunity.

Saved in:
Bibliographic Details
Title: Galectin-9-driven immune evasion constrains radiotherapy-induced systemic antitumor immunity.
Authors: Song J; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.; Department of Lung Cancer Surgery, Center of Thoracic Surgery, Tianjin Medical University General Hospital, Tianjin, China., Liu B; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China., Hsieh RC; Radiation Oncology, Medical Imaging and Radiological Science, and Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital Linkou, Taoyuan City, Taiwan., Chen HF; Graduate Institute of Cell Biology, China Medical University, Taichung, Taiwan., Yang R; Departments of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; The AHMC Dermatology and Research Center, Arcadia, California, USA., Liu J; Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Liu Z; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China., Shi S; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China., Chen Q; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China., Liu D; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China., Xiong S; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China., Hung MC; Departments of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA lsun1@tmu.edu.cn mhung@cmu.edu.tw.; Graduate Institute of Biomedical Sciences, Graduate Institute of Biochemistry and Molecular Biology, Research Center for Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan., Sun L; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China lsun1@tmu.edu.cn mhung@cmu.edu.tw.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Jul 03; Vol. 14 (7). Date of Electronic Publication: 2026 Jul 03.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2025-013675